Symbols / SIGA Stock $4.53 +0.44% SIGA Technologies, Inc.

Healthcare • Drug Manufacturers - Specialty & Generic • United States • NGM
SIGA (Stock) Chart
O: — H: — L: — C: — V: —
SMA 20: — SMA 50: — SMA 200: —
About

SIGA Technologies, Inc., a commercial-stage pharmaceutical company, focuses on the health security market in the United States. The company's lead product is TPOXX, an antiviral drug for the treatment of human smallpox disease caused by variola virus. SIGA Technologies, Inc. was incorporated in 1995 and is headquartered in New York, New York.

Stock Fundamentals
Scroll to Statements
Market Cap 324.55M Enterprise Value 168.91M Income 23.28M Sales 94.57M Book/sh 2.78 Cash/sh 2.16
Dividend Yield — Payout 0.00% Employees 49 IPO — P/E 14.16 Forward P/E 3.08
PEG 3.37 P/S 3.43 P/B 1.63 P/C — EV/EBITDA 6.96 EV/Sales 1.79
Quick Ratio 8.79 Current Ratio 11.83 Debt/Eq 0.38 LT Debt/Eq — EPS (ttm) 0.32 EPS next Y 1.47
EPS Growth — Revenue Growth -95.30% Earnings 2026-05-07 ROA 6.39% ROE 11.23% ROIC —
Gross Margin 47.49% Oper. Margin -250.38% Profit Margin 24.62% Shs Outstand 71.64M Shs Float 40.51M Short Float 7.48%
Short Ratio 4.59 Short Interest — 52W High 9.62 52W Low 4.29 Beta 1.06 Avg Volume 640.52K
Volume 362.01K Target Price — Recom None Prev Close $4.51 Price $4.53 Change 0.44%
Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
—
Mean price target
2. Current target
$4.53
Latest analyst target
3. DCF / Fair value
$7.30
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$4.53
Low
—
High
—
Mean
—

Latest analyst rating changes

Date Action Analyst Rating Change Price Target
2012-11-06 main Wedbush — → Outperform $8
News
RSS: Latest SIGA news
Insider Transactions
Filed Date Insider Relationship Transaction Shares Price Value SEC
2026-03-25 MILLER LARRY R. General Counsel — 6,920 — —
2026-03-13 LUCKSHIRE DANIEL J Chief Financial Officer — 11,503 — —
2026-03-13 NGUYEN DIEM Chief Executive Officer — 85,045 — —
2026-03-13 MILLER LARRY R. General Counsel — 21,261 — —
2026-03-13 HRUBY DENNIS E Officer — 11,445 — —
2026-01-27 NGUYEN DIEM Chief Executive Officer — 55,902 — —
2025-07-01 LUCKSHIRE DANIEL J Chief Financial Officer — 24,193 — —
2025-07-01 HRUBY DENNIS E Officer — 32,258 — —
2025-06-10 FORD HAROLD EUGENE JR Director — 19,084 — —
2025-06-10 NEMIROVSKY JULIAN Director — 19,084 — —
Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Revenue
94.57
-31.82%
138.72
-0.86%
139.92
+26.31%
110.78
Operating Revenue
94.57
-31.82%
138.72
-0.86%
139.92
+26.31%
110.78
Cost Of Revenue
49.66
+13.90%
43.60
+27.29%
34.25
+3.93%
32.96
Reconciled Cost Of Revenue
49.66
+13.90%
43.60
+27.29%
34.25
+3.93%
32.96
Gross Profit
44.91
-52.78%
95.12
-9.98%
105.66
+35.78%
77.82
Operating Expense
21.21
-15.61%
25.14
+14.03%
22.04
-37.23%
35.12
Research And Development
—
12.31
-25.06%
16.43
-27.07%
22.53
Selling General And Administration
21.21
-15.61%
25.14
+14.03%
22.04
-37.23%
35.12
Other Operating Expenses
—
—
—
—
Total Expenses
70.87
+3.11%
68.74
+22.10%
56.30
-17.30%
68.08
Operating Income
23.70
-66.13%
69.98
-16.31%
83.62
+95.83%
42.70
Total Operating Income As Reported
23.70
-66.13%
69.98
-16.31%
83.62
+95.83%
42.70
EBITDA
24.26
-65.59%
70.52
-16.20%
84.16
+94.73%
43.22
Normalized EBITDA
24.26
-65.59%
70.52
-16.20%
84.16
+96.56%
42.82
Reconciled Depreciation
0.56
+4.49%
0.54
+0.02%
0.54
+3.99%
0.52
EBIT
23.70
-66.13%
69.98
-16.31%
83.62
+95.83%
42.70
Total Unusual Items
—
—
—
0.40
Total Unusual Items Excluding Goodwill
—
—
—
0.40
Special Income Charges
—
—
—
0.00
Net Income
23.28
-60.69%
59.21
-13.01%
68.07
+100.76%
33.90
Pretax Income
30.38
-60.06%
76.07
-13.34%
87.78
+98.89%
44.13
Net Non Operating Interest Income Expense
—
—
—
0.00
Interest Expense Non Operating
—
—
—
0.00
Net Interest Income
—
—
—
0.00
Interest Expense
—
—
—
0.00
Other Income Expense
6.68
+9.74%
6.09
+46.48%
4.16
+190.07%
1.43
Other Non Operating Income Expenses
6.68
+9.74%
6.09
+46.48%
4.16
+302.70%
1.03
Gain On Sale Of Security
—
—
—
0.40
Tax Provision
7.10
-57.86%
16.86
-14.47%
19.71
+92.69%
10.23
Tax Rate For Calcs
0.00
+5.41%
0.00
-1.33%
0.00
-3.02%
0.00
Tax Effect Of Unusual Items
0.00
0.00
0.00
-100.00%
0.09
Net Income Including Noncontrolling Interests
23.28
-60.69%
59.21
-13.01%
68.07
+100.76%
33.90
Net Income From Continuing Operation Net Minority Interest
23.28
-60.69%
59.21
-13.01%
68.07
+100.76%
33.90
Net Income From Continuing And Discontinued Operation
23.28
-60.69%
59.21
-13.01%
68.07
+100.76%
33.90
Net Income Continuous Operations
23.28
-60.69%
59.21
-13.01%
68.07
+100.76%
33.90
Normalized Income
23.28
-60.69%
59.21
-13.01%
68.07
+102.60%
33.60
Net Income Common Stockholders
23.28
-60.69%
59.21
-13.01%
68.07
+100.76%
33.90
Diluted EPS
0.32
-60.98%
0.82
-13.68%
0.95
+106.52%
0.46
Basic EPS
0.33
-60.24%
0.83
-12.63%
0.95
+106.52%
0.46
Basic Average Shares
71.53
+0.39%
71.25
-0.15%
71.36
-2.15%
72.93
Diluted Average Shares
71.87
-0.05%
71.91
+0.32%
71.68
-2.54%
73.55
Diluted NI Availto Com Stockholders
23.28
-60.69%
59.21
-13.01%
68.07
+103.17%
33.50
Average Dilution Earnings
—
0.00
0.00
+100.00%
-0.40
Line Item Trend 2023-12-31
Total Assets
254.35
Current Assets
238.99
Cash Cash Equivalents And Short Term Investments
150.15
Cash And Cash Equivalents
150.15
Receivables
21.13
Accounts Receivable
21.13
Inventory
64.22
Raw Materials
8.06
Work In Process
53.65
Finished Goods
2.51
Prepaid Assets
—
Other Current Assets
3.50
Total Non Current Assets
15.36
Net PPE
1.33
Gross PPE
6.91
Accumulated Depreciation
-5.58
Properties
0.00
Machinery Furniture Equipment
0.82
Other Properties
3.68
Leases
2.42
Goodwill And Other Intangible Assets
0.90
Goodwill
0.90
Non Current Deferred Assets
11.05
Non Current Deferred Taxes Assets
11.05
Other Non Current Assets
2.08
Total Liabilities Net Minority Interest
57.49
Current Liabilities
54.12
Payables And Accrued Expenses
27.31
Payables
23.15
Accounts Payable
1.46
Dividends Payable
—
Current Accrued Expenses
4.17
Pensionand Other Post Retirement Benefit Plans Current
3.37
Total Tax Payable
21.69
Income Tax Payable
21.69
Current Debt And Capital Lease Obligation
0.56
Current Capital Lease Obligation
0.56
Current Deferred Liabilities
20.79
Current Deferred Revenue
20.79
Other Current Liabilities
2.09
Total Non Current Liabilities Net Minority Interest
3.38
Other Non Current Liabilities
3.38
Stockholders Equity
196.86
Common Stock Equity
196.86
Capital Stock
0.01
Common Stock
0.01
Share Issued
71.09
Ordinary Shares Number
71.09
Treasury Shares Number
0.00
Additional Paid In Capital
235.80
Total Equity Gross Minority Interest
196.86
Total Capitalization
196.86
Working Capital
184.87
Invested Capital
196.86
Total Debt
0.56
Capital Lease Obligations
0.56
Net Tangible Assets
195.96
Tangible Book Value
195.96
Derivative Product Liabilities
—
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Operating Cash Flow
43.47
-10.85%
48.76
-48.56%
94.80
+127.82%
41.61
Cash Flow From Continuing Operating Activities
43.47
-10.85%
48.76
-48.56%
94.80
+127.82%
41.61
Net Income From Continuing Operations
23.28
-60.69%
59.21
-13.01%
68.07
+100.76%
33.90
Depreciation Amortization Depletion
0.56
+4.49%
0.54
+0.02%
0.54
+3.99%
0.52
Depreciation And Amortization
0.56
+4.49%
0.54
+0.02%
0.54
+3.99%
0.52
Other Non Cash Items
-0.09
+99.13%
-10.46
-202.13%
10.24
+39.34%
7.35
Stock Based Compensation
3.68
+1.19%
3.64
+77.35%
2.05
+15.35%
1.78
Asset Impairment Charge
1.36
+314.00%
0.33
-43.48%
0.58
+187.50%
0.20
Deferred Tax
6.43
+3222.47%
0.19
+104.03%
-4.80
-25.34%
-3.83
Deferred Income Tax
6.43
+3222.47%
0.19
+104.03%
-4.80
-25.34%
-3.83
Operating Gains Losses
—
—
—
-0.40
Gain Loss On Investment Securities
—
—
—
-0.40
Change In Working Capital
8.26
+275.88%
-4.69
-125.91%
18.12
+767.92%
2.09
Change In Receivables
17.90
+50990.88%
-0.04
-100.14%
24.28
-36.52%
38.24
Changes In Account Receivables
17.90
+50990.88%
-0.04
-100.14%
24.28
-36.52%
38.24
Change In Inventory
-0.85
-105.52%
15.34
+160.11%
-25.52
-27.85%
-19.96
Change In Prepaid Assets
-0.61
-3.07%
-0.59
+80.36%
-3.01
-1852.71%
0.17
Change In Payables And Accrued Expense
-8.19
+57.80%
-19.41
-186.74%
22.38
+236.76%
-16.36
Change In Payable
-8.19
+57.80%
-19.41
-186.74%
22.38
+236.76%
-16.36
Change In Account Payable
-0.58
+89.92%
-5.74
-387.43%
2.00
+30.19%
1.53
Change In Other Working Capital
—
—
10.24
+50.22%
6.82
Investing Cash Flow
-0.36
-736.30%
-0.04
-95.75%
-0.02
0.00
Cash Flow From Continuing Investing Activities
-0.36
-736.30%
-0.04
-95.75%
-0.02
0.00
Capital Expenditure
-0.36
-736.30%
-0.04
-95.75%
-0.02
—
Capital Expenditure Reported
-0.36
-736.30%
-0.04
-95.75%
-0.02
0.00
Financing Cash Flow
-43.55
-0.20%
-43.46
-0.10%
-43.42
+5.52%
-45.96
Cash Flow From Continuing Financing Activities
-43.55
-0.20%
-43.46
-0.10%
-43.42
+5.52%
-45.96
Net Issuance Payments Of Debt
—
—
—
0.00
Repayment Of Debt
—
—
—
0.00
Long Term Debt Payments
—
—
—
0.00
Net Long Term Debt Issuance
—
—
—
0.00
Net Common Stock Issuance
0.00
0.00
+100.00%
-11.07
+14.87%
-13.01
Common Stock Payments
0.00
0.00
+100.00%
-11.07
+14.87%
-13.01
Common Stock Dividend Paid
-43.12
-1.06%
-42.67
-32.77%
-32.14
+2.44%
-32.94
Cash Dividends Paid
-43.12
-1.06%
-42.67
-32.77%
-32.14
+2.44%
-32.94
Repurchase Of Capital Stock
0.00
0.00
+100.00%
-11.07
+14.87%
-13.01
Net Other Financing Charges
-0.43
+45.77%
-0.80
-272.40%
-0.21
-1613.83%
-0.01
Changes In Cash
-0.43
-108.26%
5.25
-89.77%
51.36
+1281.07%
-4.35
Beginning Cash Position
155.40
+3.50%
150.15
+51.98%
98.79
-4.22%
103.14
End Cash Position
154.97
-0.28%
155.40
+3.50%
150.15
+51.98%
98.79
Free Cash Flow
43.12
-11.50%
48.72
-48.60%
94.78
+127.77%
41.61
Income Tax Paid Supplemental Data
8.20
-72.99%
30.36
+767.15%
3.50
-88.84%
31.37
Change In Income Tax Payable
-7.61
+44.32%
-13.67
-167.07%
20.38
+213.88%
-17.90
Change In Tax Payable
-7.61
+44.32%
-13.67
-167.07%
20.38
+213.88%
-17.90
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category